It was unclear the extent to which the agency has collected new intelligence on COVID-19's origins and whether that new ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

The secretary of the Department of Health and Human Services, or HHS, plays a significant role in every American's access to ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Perspective Therapeutics (CATX – Research ...

As the government continues its search for a new Drugs Controller General of India (DCGI), it has decided to extend the ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

BioCryst Pharmaceuticals Inc (BCRX) stock saw a decline, ending the day at $7.64 which represents a decrease of $-0.09 or -1.16% from the prior close of $7.73. The stock opened at $7.64 and touched a ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks over ...

The human body contains over 70,000 miles of blood vessels, lined by a single layer of endothelial cells. This inner lining, ...

Hypertension, often referred to as high blood pressure, is a major public health issue and a leading risk factor for cardiovascular diseases (CVDs) globally.

Ladenburg Thalmann has recently reduced CNS Pharmaceuticals Inc (CNSP) stock to Neutral rating, as announced on December 28, 2020, according to Finviz. Analyst ratings are significant because they ...